A case of NMO (neuromyelitis optica) spectum disorder triggered by interferon alpha, which involved extensive pyramidal tract lesion of the brain

Clinical Neurology

Volumn 52, Issue 1, 2012, Pages 19-24

  Yamasaki, Masayoshi ^a   Matsumoto, Katsuhisa ^a   Takahashi, Yu ^a   Nakanishi, Hirotaka ^b   Kawai, Yoshinari ^b   Miyamura, Masanori ^a  

^a Ise Municipal General Hospital   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti aquaporin4 antibody; Brain lesion; Interferon alpha; NMO (neuromyelitis optica) spectrum disorder; Pyramidal tract

Indexed keywords

AQUAPORIN 4 ANTIBODY; METHYLPREDNISOLONE; PEGINTERFERON ALPHA; PROTEIN ANTIBODY; RIBAVIRIN; UNCLASSIFIED DRUG;

AGED; ANTIVIRAL THERAPY; ARTICLE; CASE REPORT; COMBINATION CHEMOTHERAPY; CORONA RADIATA (BRAIN); CORPUS CALLOSUM; CORTICOSTEROID THERAPY; DRUG MEGADOSE; DRUG WITHDRAWAL; DYSARTHRIA; FEMALE; HEMIPARESIS; HEPATITIS C; HUMAN; IMAGE ANALYSIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PEDUNCULAR ANSA; PYRAMIDAL SIGN; SERODIAGNOSIS; VISUAL FIELD DEFECT; WHITE MATTER;

AGED; AQUAPORIN 4; AUTOANTIBODIES; BIOLOGICAL MARKERS; FEMALE; HEPATITIS C; HUMANS; INTERFERON-ALPHA; METHYLPREDNISOLONE; NEUROMYELITIS OPTICA; PULSE THERAPY, DRUG; PYRAMIDAL TRACTS; TREATMENT OUTCOME;

EID: 84856398930     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: 10.5692/clinicalneurol.52.19     Document Type: Article

References (23)

1. Larrey D, Marcellin P, Fréneaux E, et al. Exacerbation of multiple sclerosis after the administration of recombinant human interferon alpha. JAMA 1989:261:2065. (Pubitemid 19097968)
2. Manesis EK, Petrou C, Brouzas D, et al. Optic tract neuropathy complicating low-dose interferon treatment. J Hepatol 1994;21:474-477. (Pubitemid 24308776)
3. Isler M, Akhan G, Bardak Y, et al. Dry cough and optic neuritis:two rare complications of Interferon α treatment in chronic viral hepatitis. Am J Gastroenterol 2001;96:1303-1304. (Pubitemid 32319186)
4. Matsuo T, Takabatake R. Multiple sclerosis-like disease secondary to alpha interferon. Ocul Immunol Inflamm 2002;10:299-304. (Pubitemid 36886373)
5. Kataoka I, Shinagawa K, Shiro Y, et al. Multiple sclerosis associated with interferon-alpha therapy for chronic myelogenous leukemia. Am J Hematol 2002;70:149-153.
6. Höftberger R, Garzuly F, Dieres HP, et al. Fulminant central nervous system demyelination associated with interferon-α therapy and hepatitis C virus infection. Mult Scler 2007;13:1100-1106. (Pubitemid 351541413)
7. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica Neurology 2006;66:1485-1489. (Pubitemid 43958540)
8. Dusheiko G. Side effects of alpha interferon in chronic hepatitis C. Hepatology 1997;22 Suppl 1:112S-121S. (Pubitemid 27388083)
9. Durelli L, Bongioanni MR, Cavallo R, et al. Chronic systemic high-dose recombinant interferon alpha-2a reduces exacerbation rate, MRI signs of disease activity, and lymphocyte interferon gamma production in relapsing-remitting multiple sclerosis. Neurology 1994;44:406-413. (Pubitemid 24098135)
10. Myhr KM, Riise T, Lilleås FEG, et al. Interferon-α2a reduces MRI disease activity in relapsing-remitting multiple sclerosis. Neurology 1999;52:1049-1056. (Pubitemid 29161618)
11. Warabi Y, Matsumoto Y, Hayashi H. Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination. J Neurol Sci 2010:291:37-43.
12. Shimizu Y, Yokoyama K, Misu T, et al. Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis. J Neurol 2008;255:305-307.
13. Shimizu J, Hatanaka Y, Hasegawa M, et al. IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum. Neurology 2010;75:1423-1427.
14. Bekisz J, Schmeisser H, Hernandez J, et al. Human interferons alpha, beta and omega. Growth Factors 2004;22:243-251. (Pubitemid 40123402)
15. Pittock SJ, Lennon VA, Krecke K, et al. Brain abnormalities in neuromyelitis optica Arch Neurol 2006;63:390-396.
16. Nakashima I, Fujihara K, Miyazawa I, et al. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 2006;77:1073-1075. (Pubitemid 44338534)
17. BRAIN and NERVE 2010;62:933-943.
18. Nakamura M, Misu T, Fujihara K, et al. Occurrence of acute large and edematous callosal lesions in neuromyelitis optica. Mult Scler 2009;15:695-700.
19. Palmer S, Bradley WG, Chen DY, et al. Subcallosal striations:early findings of multiple sclerosis on saggital, thin section, Fat FLAIR MR Images. Radiology 1999;210:149-153. (Pubitemid 29004296)
20. Ito S, Mori M, Makino T, et al. "Cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica. Ann Neurol 2009;66:425-428.
21. Matsushita T, Isobe N, Piao H, et al. Reappraisal of brain MRI features in patients with multiple sclerosis and neuromyelitis optica according to anti-aquaporin4 atatus. J Neuro Sci 2010;291:37-43.